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Influenza A virus (IAV) replicates in the upper respiratory tract of humans at 33 6C and in the
intestinal tract of birds at close to 41 6C. The viral RNA polymerase complex comprises three
subunits (PA, PB1 and PB2) and plays an important role in host adaptation. We therefore
developed an in vitro system to examine the temperature sensitivity of IAV RNA polymerase
complexes from different origins. Complexes were prepared from human lung epithelial cells
(A549) using a novel adenoviral expression system. Affinity-purified complexes were generated
that contained either all three subunits (PA/PB1/PB2) from the A/Viet/1203/04 H5N1 virus (H/H/
H) or the A/WSN/33 H1N1 strain (W/W/W). We also prepared chimeric complexes in which the
PB2 subunit was exchanged (H/H/W, W/W/H) or substituted with an avian PB2 from the A/
chicken/Nanchang/3-120/01 H3N2 strain (W/W/N). All complexes were functional in
transcription, cap-binding and endonucleolytic activity. Complexes containing the H5N1 or
Nanchang PB2 protein retained transcriptional activity over a broad temperature range (30–
42 6C). In contrast, complexes containing the WSN PB2 protein lost activity at elevated
temperatures (39 6C or higher). The E627K mutation in the avian PB2 was not required for this
effect. Finally, the avian PB2 subunit was shown to confer enhanced stability to the WSN 3P
complex. These results show that PB2 plays an important role in regulating the temperature
optimum for IAV RNA polymerase activity, possibly due to effects on the functional stability of the
3P complex.
INTRODUCTION
Among theviral factorsthat contributetovirulenceandhost
range of influenza A viruses (IAVs) are the viral polymerase
proteins (Almond, 1977; Gabriel et al., 2005, 2007; Hatta
et al., 2001; Murakami et al., 1988). The IAV polymerase is a
heterotrimeric protein (3P) complex comprised of PB1, PB2
and PA. PB1 contains conserved sequence elements found in
other RNA-dependent RNA polymerases (Deng et al., 2005;
Fodor & Brownlee, 2002; Lamb & Krug, 2001), and binds
directly to the viral (vRNA) and complementary RNA
(cRNA) promoter sequences. PA is needed for transcription
and replication (Fodor et al., 2002; Hara et al., 2006; Perales
et al., 2000; Regan et al., 2006), and for efficient nuclear
accumulation of PB1 (Fodor & Smith, 2004; Sanz-Ezquerro
et al., 1995). The third subunit, PB2, localizes to the nucleus
and to mitochondria (Carr et al., 2006). It binds to cap
structures of host mRNAs which are then cleaved by the
endonucleolytic activity of PB1 (Guilligay et al., 2008; Li et
al., 2001; Plotch et al., 1981). PB2 also plays a major role in
host adaptation (Finkelstein et al., 2007; Gabriel et al., 2008;
Hatta et al., 2001; Labadieet al., 2007; Li et al., 2005; Naffakh
et al., 2000; Salomon et al., 2006). One factor that
contributes to host adaptation is the temperature optimum
for virus replication. IAV replicates in the upper respiratory
tract of humans at 33 uC and in the intestinal tract of birds
close to 41 uC. In cell culture, human IAV can replicate at
temperatures ranging from 33 uCt o3 7 uC, but not at
elevated temperatures such as 42 uC. In contrast, most avian
IAVs exhibit cold sensitivity with reduced replication at
33 uC, but efficient replication at 37 uCo r4 2uC (Massin et
al., 2001; Murakami et al., 1988; Murphy et al., 1982a, b).
It has been shown that amino acid residue 627 in PB2 is
one of the main determinants for cold sensitivity of the
avian IAV and for viral pathogenicity in mammalian hosts
Published online ahead of print on 11 September 2008 as DOI
10.1099/vir.0.2008/006254-0.
A supplementary figure is available with the online version of this paper.
Journal of General Virology (2008), 89, 2923–2932 DOI 10.1099/vir.0.2008/006254-0
2008/006254 G 2008 SGM Printed in Great Britain 2923(Hatta et al., 2007; Massin et al., 2001; Murakami et al.,
1988; Torreira et al., 2007): the presence of lysine at
position 627 (K
627), instead of the glutamic acid (E
627) that
is found in avian viruses, is crucial for high virulence in
mice (Hatta et al., 2001). This amino acid does not
determine the cell tropism of the virus (Shinya et al., 2004),
but instead enhances viral growth in mice and probably in
humans (Hatta et al., 2007; Salomon et al., 2006). The
mechanism underlying this observation still needs to be
elucidated.
Most studies on temperature sensitivity of IAVs have been
performed at the level of viral transcription-replication. We
were interested in how different temperatures directly
affect viral RNA polymerase activity at the transcriptional
level. To do this, we elected to use two well-characterized
IAVs: (i) the mouse-adapted A/WSN/33 H1N1 virus
(‘WSN’) and (ii) the A/Viet/1203/04 H5N1 virus
(‘VN1203’). WSN has been described to replicate with
about tenfold lower efficiency at 39.5 uC compared with
34 uC, as measured by plaque assay (Kawaguchi et al.,
2005). In contrast, the VN1203 virus has been shown to
replicate efficiently at both low (34 uC) and high
temperatures (41 uC) (Hatta et al., 2007).
We purified 3P complexes (PA/PB1/PB2) from the
VN1203 (H/H/H) and WSN (W/W/W) strains and
compared the effect of temperature on cap-independent
and cap-dependent transcription. In addition, we
exchanged the PB2 subunits between these two complexes
(H/H/W, W/W/H) or substituted the PB2 subunit with an
avian subunit from the A/chicken/Nanchang/3-120/01
strain (H3N2) (W/W/N). We developed an adenoviral
expression system which is attractive, because recombinant
adenoviruses can enter a broad range of cells, including
IAV-susceptible human lung epithelial cells (A549). As a
result, it is possible to prepare authentic IAV polymerase
complexes that contain associated host cell factors that
participate in complex formation and/or polymerase
function. Using this approach, we show here that PB2
directly affects the temperature optimum for IAV tran-
scription, and that incorporation of an H5N1 or avian PB2
subunit into the IAV 3P complex results in greatly
increased polymerase activity at elevated temperatures
characteristic of birds. We also show that this effect of
the H5N1 and avian PB2 subunits does not depend on the
presence of a glutamic acid residue at position 627 of PB2.
Finally, our results suggest that PB2 may exert its effect on
the temperature optimum of the IAV RNA polymerase by
influencing the functional stability of this trimeric protein
complex.
METHODS
Influenza virus strains, vectors and cells. Each polymerase
subunit of the WSN (H1N1) strain (A/WSN/33) was subcloned from
pcAGGS-PA/PB1/PB2WSN (gift of Dr Y. Kawaoka, University of
Wisconsin-Madison, WI, USA). The PB2 gene was amplified by
reverse-transcription PCR from the Nanchang (H3N2) strain (A/
chicken/Nanchang/3-120/01), obtained from Dr R. Webster, St Jude
Children’s Research Hospital, Memphis, TN, USA (Liu et al., 2003).
The E627K mutation was introduced by site-directed mutagenesis
(Quick-Change mutagenesis kit, Stratagene). The polymerase genes of
the VN1203 (H5N1) strain (A/Vietnam/1203/04) were assembled
from synthetic oligonucleotides by GENEART (GenBank accession
nos EF467808, AY818132.1, AY651719.1).
PA from the WSN and the VN1203 strain were tagged at the C
terminus with a tandem-affinity purification (TAP)-tag. The TAP-tag
was constructed by overlapping PCR-mutagenesis, resulting in a C-
terminal TAP where the thrombin cleavage site was followed by a
66His tag, a tobacco etch virus (TEV) cleavage site and an IgG-
binding domain (protein A domain). Briefly, the ZZ domain of
BG1766 (Malkowski et al., 2007) was amplified by overlapping PCR
introducing a TEV cleavage site. The amplified PCR product was
ligated at the 59-terminal EcoRV site to a dsDNA fragment
(TCTAGACTGGTGCCGCGCGGCAGCCATCATCATCACCATCAT-
GATATC) containing a thrombin site and a 66His tag. WSN or
VN1203 PA were fused at their C terminus to the TAP-tag.
Human embryonic kidney (HEK293A or QBI-HEK 293CymR) or
human lung endothelial cells (A549) were grown at 37 uC and
maintained in DMEM supplemented with 10% fetal bovine serum,
50 IU penicillin ml
21,5 0 mg streptomycin ml
21 and 2 mM
glutamine.
Adenovirus production. Recombinant adenoviruses expressing
either LacZ or PB2 from the Nanchang strain (N or NE627K) or PA-
TAP, PB1 or PB2 from the WSN or the VN1203 strain were created
from pShCMV by homologous recombination into AdEasy and
propagation in HEK293A cells (AdEasy system, Stratagene). Only the
adenovirus expressing PB2 from the VN1203 strain was constructed
differently, by cloning PB2 into the pAdenoVator-CMV(CuO)
plasmid followed by recombination into AdEasy and propagation in
QBI-HEK 293CymR cells (Qbiogene). The viruses were purified by
CsCl density-gradient centrifugation and dialysis. Viral titres were
determined by quantitative real-time PCR (Heim et al., 2003).
Polymerase purification. A549 cells (6610
6 in a T-225 flask) were
transduced the following day with each of the three adenoviruses
(rAd5-PB1, -PB2, -PA-TAP) at an m.o.i. of 1000 (80% transduction
efficiency); for adenoviruses expressing the codon-optimized genes
PA, PB1 and PB2 from the VN1203 (H5N1) strain an m.o.i. of about
100 was used.
Nuclear and cytoplasmic extracts were prepared 48 h post-infection
(Nuclear Extract kit, Active Motif) and purified using the TAP
method (described below).
Lysates from whole cells were prepared 48 h post-infection in 3 ml
ice-cold 16 RIPA buffer (Upstate) supplemented with 1 mM NaF,
1 mM PMSF, 1 mM NaVO3,1ml Protease Inhibitor Cocktail (P8340,
Sigma).
Poly-Prep Chromatography Columns (0.864 cm, Bio-Rad) were
loaded with 300 ml IgG Sepharose 6 fast flow bead suspension
(Amersham) and washed with IPP-150 buffer (Puig et al., 2001). Pre-
cleared cell lysate (3 ml, corresponding to cells from one 225 cm
2
flask) was mixed with 7 ml IPP-150 buffer and rotated for 2–4 h at
4 uC in the presence of IgG. The columns were washed with IPP-150
then with TEV-cleavage buffer (IPP-150 supplemented with 1 mM
DTT and 0.5 mM EDTA). The beads were transferred to Micro Bio-
Spin Chromatography columns (Bio-Rad) and incubated at 4 uC
overnight in 300 ml TEV buffer containing TEV-enzyme (30 U). The
eluate was collected by low speed centrifugation and dialysed (50 mM
Tris-Cl (pH 7.5), 1 mM EDTA, 200 mM NaCl, 10% glycerol, 1 mM
DTT) using a 20000 MWCO Dialysis Cartridge (Pierce).
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and separated by 7.5% SDS-PAGE prior to immunoblotting. For
silver staining, gels were treated according to the manufacturer’s
protocol (SilverXpress Silver Staining kit, Invitrogen).
Antibodies used were (Santa Cruz): anti-a-tubulin (mouse, TU-02),
anti-PB1 (vK-20), anti-PB2 (vN-19), anti-actin (H-196) and anti-goat
IgG HRP (Sc-2033). ECL anti-rabbit IgG HRP (NA934V) and ECL
anti-mouse IgG HRP (NA931V) were purchased from Amersham and
anti-Penta-His (mouse) from Qiagen.
ApG- and globin-primed transcription assay. The ApG-primed
transcription assay was performed basically as described elsewhere
(Fodor et al., 2002). The amount of purified 3P complex used in
transcription assays was normalized either in terms of PB2 content (as
measured by immunoblotting) or in terms of transcriptional activity
at 30 uC. IgG-purified, normalized samples were mixed with
transcription buffer (25 mM Tris-Cl, pH 7.5, 100 mM KCl, 5 mM
MgCl2, 0.1 mM EDTA, 2 mM DTT, 0.25 Nonidet P-40, 12.5%
glycerol) supplemented with 0.25 U RNasin ml
21, 1 mM each ATP/
UTP/CTP, 0.1 mM GTP, 0.15 mM [a-
32P]GTP (3000 Ci mmol
21),
1.6 mM each 59-( 5 9-AGUAGAAACAAGGCC-39) and 39-end vRNA
(59-GGCCUGCUUUUGCU-39) and 0.3 mM ApG (Biosynthesis).
The reaction volume (5 ml) contained 2 ml normalized protein
sample. Transcription was allowed to occur for 1 h at 30, 34, 37, 39
or 42 uC and the reaction was terminated by the addition of 4 ml
Stop-buffer (10 mM EDTA pH 8.0, 90% formamide). Transcription
products were separated by 18% PAGE in 7 M urea and detected by
autoradiography using a PhosphorImager (Molecular Dynamics).
Densitometry was performed using OptiQuant (Version 3.10,
Packard Instrument).
The globin-primed (cap-dependent) transcription assay was per-
formed similarly. Instead of ApG rabbit-globin mRNA (Sigma) was
used as a cap-donor (10 ng per 5 ml reaction volume) and the
incubation time was 90 min (Hara et al., 2006).
Thermo-stability assay. Equivalent amounts of polymerase in 2 ml
(as determined by polymerase activity at 30 uC) were pre-incubated at
30 uC for 5, 10, 15, 20, 25, 30, 60 and 120 min. After pre-incubation
3 ml ApG-containing transcription buffer, supplemented as described
above, was added to the sample and transcription was allowed to
occur at 30 uC for 1 h.
RESULTS
Adenoviral expression of the IAV polymerase in
human lung epithelial cells (A549)
A549 cells were transduced with either a LacZ-expressing
control adenovirus, a PAWSN-TAP-expressing virus or a
combination of three viruses expressing PAWSN-TAP,
PB1WSN and PB2WSN (W/W/W). To test whether the
adenovirus-mediated expression system might alter the
normal distribution of the IAV 3P complex, we analysed
the cellular distribution of PA in the absence or presence of
PB1 and PB2. To do this, nuclear and cytoplasmic extracts
were prepared from vector-transduced A549 cells, sepa-
rated by SDS-PAGE and blotted with antibodies directed
against PA, PB1 and PB2.
To confirm the effectiveness of our subcellular fractiona-
tion method, we also examined the presence of a-tubulin
and actin (both cytoplasmic proteins), and of RanBP5
(which is found predominantly in the cytoplasm, but also
in the nucleus) (Deane et al., 1997). As shown in Fig. 1(a),
nuclear fractions were lacking in both a-tubulin and actin,
but contained RanBP5. Fig. 1(a) also shows that PA, when
expressed alone, mainly accumulated in the cytoplasm with
less than 10% in the nucleus; in contrast, when co-
expressed with PB1 and PB2 (W/W/W), PA was readily
detected in the nucleus (about 30%), as expected (Fodor &
Smith, 2004; Nieto et al., 1992). Thus, the adenovirus
expression system had no detectable effect on the expected
subcellular localization of the IAV 3P complex and its
individual component proteins.
Transcriptional activity of the WSN 3P complex
purified from A549 cells
The polymerase complex was purified from whole-cell
lysates, nuclear and cytoplasmic extracts by binding PA-
TAP via its protein A domain to IgG-beads. All proteins
that interact with PA, including PB1, PB2 and host factors
binding to the 3P complex, were expected to be pulled
down by this approach. The complex was released from the
beads by cleavage with TEV-enzyme and the purity of the
complex was analysed by silver staining (Fig. 1b, d).
We next tested the transcriptional activity of the purified
polymerase complexes using an ApG-primed transcription
assay in which the 39- and 59-vRNA and the dinucleotide
ApG were provided. In this assay, the 3P complex initiates
extension of the bound dinucleotide; the fully extended
product of this reaction is a 14 nt RNA fragment. No
extension products were detected when the ApG-primed
transcriptional assay was performed with IgG-purified
extracts from cells expressing LacZ or PA alone. Only the
fully assembled trimeric polymerase complex (W/W/W)
generated an extension product (Fig. 1c). We did not
observe any difference in transcriptional activity of purified
polymerase complexes from total cell lysates, or from either
nuclear or cytoplasmic extracts (Fig. 1c); the apparently
lower transcriptional activity of the nuclear polymerase
complex can be attributed simply to the lower amount
(~30% less) of assembled 3P complex present in the
nucleus (Fig. 1b). For further biochemical studies, 3P
complexes were isolated in larger quantities from total cell
lysates and analysed by silver staining (Fig. 1d, top panel).
The most abundant protein in the purified complex was
PA, which was precipitated as a monomer, or complexed
with either PB1 (PA/PB1) or PB1 and PB2 (PA/PB1/PB2).
The second most abundant protein was PB1, which was
pulled down as a dimeric (PA/PB1) or trimeric (PA/PB1/
PB2) complex. The presence of dimeric (PA/PB1) complex
can be inferred by the presence of the host-factor RanBP5
(Fig. 1d, bottom panel; Supplementary Fig. S1, available in
JGV Online) that is known to interact with PB1 or PB1/PA
(Deng et al., 2006). PB2 was the least abundant protein
since it was only precipitated in the context of the intact 3P
complex (PA/PB1/PB2); therefore in our future experi-
ments, PB2 content was used to normalize overall levels of
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following experiments 3P complexes purified from total
cellular lysates were utilized.
The 3P complex from the A/Viet/1203/04
(VN1203) strain is highly active, and both the WSN
and VN1203 complexes are competent for cap-
independent and cap-dependent transcription
We purified 3P complexes (PA/PB1/PB2) from the
VN1203 (H5N1) (H/H/H) and the A/WSN/33 (H1N1)
(W/W/W) strains as well as complexes in which the PB2
subunits were exchanged (H/H/W, W/W/H) or omitted
(H/H). The purified complexes were analysed by silver
staining and immunoblotting against PB2 (Fig. 2a top and
bottom panel, respectively). All complexes, except the
negative control (H/H), were able to initiate transcription
at 30 uC in a cap-independent fashion by utilizing ApG as a
primer (Fig. 2b, top panel). A fully extended primer that
yielded a 14 nt transcript was detected for all complexes.
An additional band above the 14 nt extension product is
likely due to some terminal transferase ability of the IAV
polymerase.
Influenza viruses use a cap-snatching mechanism to initiate
transcription, which involves recognition and binding of
the cap structure of host mRNAs by PB2, followed by
cleavage of the capped mRNA at nucleotide 10–14 by the
endonucleolytic activity of PB1 (Guilligay et al., 2008; Li et
al., 2001; Plotch et al., 1981). These short RNAs are then
utilized by the polymerase as primers to initiate transcrip-
tion. We expected that cleavage of the provided cap-donor
by the 3P complex would result in the generation of short
RNAs able to bind to the 39-vRNA template (14 nt). The
resulting transcription product (cap primer +14 nt) was
detected as a triplet band in our assays (Fig. 2b, bottom
panel), which could be due to multiple cleavage sites in the
primer or to residual nuclease activity (Fodor et al., 2002).
All purified complexes were able to utilize rabbit globin
mRNA to prime transcription. Thus, all of the complexes,
except the negative control (H/H), were competent for
cap-binding and endonucleolytic activity. Only a fully
assembled, trimeric complex is transcriptionally active
(Deng et al., 2005; Perales & Ortin, 1997).
Relative levels of transcriptional activity for the various
complexes were measured by normalizing to the levels of
PB2 (Fig. 2a, bottom panel). This analysis revealed that the
VN1203 3P complex was 40-fold more active in the ApG-
primed (Fig. 2c) and about 30-fold more active in the cap-
primed transcription assay (Fig. 2d) than the WSN 3P
complex, and that the PB2 subunit contributes to this
enhanced activity. These findings are consistent with those
reported by Taubenberger, who noted that IAV polymerase
Fig. 1. Subcellular distribution and activity of
purified, adenovirus-expressed WSN polymer-
ase. (a) A549 cells were transduced with
rAd5-PAWSN-TAP alone or with a combination
of rAd5-PAWSN-TAP, -PB1WSN and -PB2WSN
(W/W/W). Nuclear and cytoplasmic extracts
were analysed by immunoblotting using PA-,
PB1- or PB2-specific antibodies. The effec-
tiveness of the subcellular fractionation
method was confirmed by probing against
the cytoplasmic proteins, actin and b-tubulin
as well as against RanBP5 (which is found
both in the cytoplasm and nucleus). NS, non-
specific protein band detected when probing
against PB1/2. Cells transduced with an
adenovirus vector expressing LacZ served as
a negative control. Twofold more cell equiva-
lents were loaded for the nuclear extracts than
the cytoplasmic extracts. (b) IgG-purified
nuclear and cytoplasmic extracts were ana-
lysed by silver staining prior to (c) comparison
with total cell lysate in an ApG-primed
transcription assay (1 h at 30 6C). Extracts
from equivalent numbers of transduced A549
cells were used. (d) IgG-purified extracts from
total cellular lysates were analysed by silver
staining (upper panel) and immunoblotting
against RanBP5 (lower panel). The positions
of PA, PB1 and PB2 are shown on the right.
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activity compared with those containing human IAV
proteins (Taubenberger et al., 2005). The biological
significance and mechanistic underpinnings of this obser-
vation will require further investigation.
The VN1203 polymerase is active at elevated
temperatures, and the PB2 subunit is sufficient to
confer broad temperature tolerance on the WSN
polymerase
The purified polymerase complexes were subjected to the
ApG- (Fig. 3a) or globin-primed (Fig. 3b) transcription
assay. Reactions were run at 30 uC and at a range of
temperatures selected on the basis of their physiological
relevance to influenza virus replication (34, 37, 39 and
42 uC). In these experiments, the amount of input 3P
complex was standardized by using an equivalent amount
of functionally active complex, as determined on the basis
of transcriptional activity at 30 uC. The WSN complex
(W/W/W) extended the ApG primer best at temperatures
ranging from 30 to 34 uC; activity was reduced by more
than twofold at 37 uC and more than tenfold at elevated
temperatures (39–42 uC) (Fig. 3a). In contrast, the VN1203
complex (H/H/H) extended the primer best at 34–39 uC,
and retained 25% of its activity at elevated temperature
(42 uC). Chimeric complexes in which the PB2 subunit was
exchanged (H/H/W, W/W/H) exhibited a temperature
sensitivity profile similar to that of the WT complexes from
which the PB2 subunit was derived – i.e. the H/H/W
complex was minimally active at elevated temperatures,
while the W/W/H complex retained a high level of
functionality at 39–42 uC (Fig. 3a). In contrast, the
presence of excess PA/PB1 heterodimers in the WSN
complexes (W/W/W) had no effect on the thermotolerance
of the polymerase (Supplementary Fig. S1).
Results from the cap-primed transcription assay (Fig. 3b)
were essentially equivalent to those obtained from the
ApG-primed assay. The W/W/W complex extended the
capped mRNA best at 30 uC, and its activity was reduced to
50% at 34–37 uC and to less than 20% at 39–42 uC. In
contrast, the H/H/H complex extended the capped primer
best at 30–39 uC, and retained significant activity at 42 uC.
In this assay, the temperature sensitivity profile of the
activity of the chimeric complexes was again determined by
the PB2 subunit.
Overall, results obtained with the cap-independent and
cap-dependent transcription assays were very similar.
One minor difference was that, in the ApG-primed
transcription assay, we observed a somewhat more
pronounced difference in temperature sensitivity between
complexes harbouring the WSN PB2 subunit (W/W/W,
H/H/W) and complexes containing the VN1203 PB2
protein (H/H/H, W/W/H). Collectively, these results
showed that the VN1203 complex is active at a broad
range of temperatures, that this property is dependent on
the PB2 subunit, and that this phenotype can be
transferred to the WSN 3P complex simply by exchanging
the PB2 subunit.
Fig. 2. The H5N1 3P complex is more active
than the WSN 3P complex in both cap-
independent and cap-dependent transcription.
(a) Purified 3P complexes from the VN1203
(H/H/H) and WSN (W/W/W) viruses, along
with chimeric (H/H/W and W/W/H) and
dimeric complexes (H/H; negative control),
were detected by silver staining and immuno-
blotting against PB2 (top and bottom panel,
respectively). PB2-normalized complexes were
used in functional assays (30 6C). (b) The
complexes were analysed for cap-independent
(ApG) or cap-dependent transcription (top
and bottom panel, respectively). The transcrip-
tion products in the ApG-primed assay (14 nt
long transcript) and in the globin-primed assay
(triplet band; capped primer +14 nt) were
detected by autoradiography. (c, d)
Quantitative data for the ApG- and the cap-
RNA-primed assays are shown. The data were
normalized in terms of fold activity over the
activity of the W/W/W complex. The results
shown represent mean transcriptional activity
data from at least three independent assays.
Bars, SEM.
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complex transcriptionally more active
In light of the putative avian origin of H5N1 viruses, such
as A/Viet/1203/04, we wondered whether an avian PB2
(H3N2) protein might have similar properties to the
human H5N1 PB2 protein. To test this hypothesis, we
cloned and expressed the PB2 subunit from the A/chicken/
Nanchang/3-120/01 strain. We then purified 3P complexes
(PA/PB1/PB2) from the WSN strain as well as complexes in
which the PB2 subunit was substituted with an avian PB2
(W/W/N) or a mutated avian PB2 (W/W/NE627K). An E to
K mutation in an avian PB2 has been shown to significantly
enhance polymerase activity in mammalian cells, as
measured in transcription–replication experiments
(Labadie et al., 2007; Massin et al., 2001). The purified
complexes were analysed by silver staining and by
immunoblotting against PB2 (Fig. 4a top and bottom
panel, respectively). All complexes were able to initiate
transcription at 30 uC in a cap-independent and a cap-
dependent fashion (Fig. 4b top and bottom panel,
respectively). Complexes containing the avian PB2 subunit
were found to have 20-fold greater activity than the WSN
3P complex in the ApG-primed and 10–20-fold greater
activity in the globin-primed transcription assay.
Interestingly, in both assays an E627K mutation in the
avian PB2 resulted in a slight increase in activity.
An avian PB2 confers broad temperature
tolerance on the WSN 3P complex
The purified complexes (W/W/W, W/W/N) were evaluated
for their activity over a range of temperatures by using an
equivalent amount of functionally active complex as
described above. In the ApG- and cap-primed transcription
assay (Fig. 5a and c) the W/W/N complex had optimal
activity at 30–39 uC (peaking at 37 uC and modestly
declining at 42 uC). We then quantified the transcriptional
activities of all three complexes (W/W/W, W/W/N, W/W/
NE627K) in the ApG- and cap-primed transcription assay
(Fig. 5b and d, respectively) and found, that an E627K
mutation slightly shifted the temperature optimum from
37 uCt o3 9uC.
Collectively, these results suggest that an avian PB2 subunit
behaves similarly to the VN1203 (H5N1) PB2 subunit, and
that it too enhances the activity of the WSN 3P complex at
elevated temperatures.
An avian PB2 confers enhanced functional
stability on the WSN 3P complex
To investigate the mechanistic basis for the increased
thermal tolerance of complexes containing the avian PB2
subunit, we conducted a comparative analysis of the
thermostability of the W/W/W and the W/W/N complexes.
For this experiment, an equal amount of 3P complexes (as
determined by functional activity at 30 uC) was preincu-
bated at 30 uC. This occurred in the absence of any vRNA
or nucleosides over different time periods (0–120 min).
The transcriptional activity of each complex was then
measured (30 uC, 1 h). It has been reported that the WSN
3P complex is heat labile in the absence of vRNA (Brownlee
& Sharps, 2002), which was confirmed by our analysis. For
the W/W/W complex we observed an exponential decay in
transcriptional activity when pre-incubated at 30 uC
(Fig. 6a, b); the half-life of the complex was estimated at
5–12 min at this temperature (Fig. 6b). However, the
W/W/N complex was very stable over the entire time-
period – with a loss of activity of only about 25% over a
Fig. 3. The human H5N1 3P complex is active at high
temperatures and the H5N1 PB2 subunit confers this same
phenotype on the WSN 3P complex. Equivalent amounts of
polymerase complex (as determined by polymerase activity at
30 6C) were tested for transcriptional activity at different
temperatures (30, 34, 37, 39, 42 6C). (a, b) Representative
autoradiograms and quantitative data (top and bottom panel,
respectively) for the ApG- (a) and the cap-RNA-primed (b) assays
are shown. The data were normalized in terms of percentage of the
amount of fully extended product at 30 6C (as quantified by
Phosphorimager analysis); the results shown represent mean
transcriptional activity data from at least four independent assays.
Bars, SEM.
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subunit confers greater stability on the WSN 3P complex
and extends the functional half-life of the complex. While
the functional activity of the W/W/W complex rapidly
declined during incubation at 30 uC, this could not be
attributed to simple physical dissociation of the complex,
since it remained intact even in the absence of vRNA
(Fig. 6c).
Fig. 4. An avian PB2 subunit increases the
activity of the WSN 3P complex at 30 6C. (a)
Purified 3P complexes from the WSN (W/W/
W) virus were prepared, along with complexes
in which the PB2 subunit was omitted (W/W)
or substituted by the PB2 from the avian
Nanchang virus (W/W/N) or a mutated deriv-
ative (W/W/NE627K). The purified complexes
were detected by silver staining and immuno-
blotting against PB2 (top and bottom panel,
respectively). PB2-normalized complexes were
used in functional assays (30 6C). (b) The
complexes were analysed for cap-independent
(ApG) or cap-dependent transcription (top
and bottom panel, respectively). The transcrip-
tion products in the ApG primed assay (14 nt
long transcript) and in the globin-primed assay
(triplet band; capped primer +14 nt) were
detected by autoradiography. (c, d)
Quantitative data for the ApG- and the cap-
RNA-primed assays are shown. The data were
normalized in terms of fold activity over the
activity of the W/W/W complex. The results
shown represent mean transcriptional activity
from at least three independent assays. Bars,
SEM.
Fig. 5. An avian PB2 subunit confers broad
temperature tolerance on the WSN 3P com-
plex independently of amino acid residue 627.
Purified 3P complexes were prepared from the
WSN virus (W/W/W), along with complexes in
which the PB2 subunit was substituted by an
avian PB2 (W/W/N) or a mutated derivative
(W/W/NE627K); an extract prepared from
LacZ-expressing cells (LacZ) was used as a
negative control. Equivalent amounts of poly-
merase complex (as determined by polymerase
activity at 30 6C) were tested for transcrip-
tional activity at different temperatures (30, 34,
37, 39, 42 6C). Representative autoradio-
grams (a, c) and quantitative data (b, d) are
shown for the ApG- (a, b) and the cap-RNA-
primed (c, d) assays. The data were normalized
in terms of percentage of the amount of fully
extended product at 30 6C (as quantified by
Phosphorimager analysis); the results shown
represent mean transcriptional activity from at
least four independent assays. Bars, SEM.
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Some H5N1 avian influenza viruses (Claas et al., 1998; Li
et al., 2004) exhibit high pathogenicity in humans with
pandemic potential (Gambotto et al., 2008). This under-
scores the need to better understand the mechanisms that
determine the ability of emerging influenza viruses to cross
the species barrier into humans. This process is regulated in
part by the viral haemagglutinin (HA) and host sialic acid
receptors (Suzuki et al., 2000). The viral polymerase
complex is also recognized to play an important role in
IAV host-cell specificity and pathogenicity (Gabriel et al.,
2005, 2007; Labadie et al., 2007; Massin et al., 2001;
Salomon et al., 2006), but the underlying basis for this
remains poorly understood.
In this report, we show that the IAV 3P complex can be
successfully purified from human lung epithelial cells using
an adenoviral system. We analysed the functional activity
of IAV polymerase complexes from the WSN (H1N1) and
VN1203 (H5N1) strains, as well as chimeric complexes in
which the PB2 subunits were exchanged. Our data show
that the H5N1 polymerase complex has more robust
thermotolerance than its WSN counterpart, which is active
over a narrow temperature range (30–34 uC) with a more
than 50% reduced activity at 37 uC. This effect can be
attributed to the PB2 subunit, since a simple exchange of
this protein was associated with substantial changes in the
temperature sensitivity of the polymerase activity. This
effect does not depend on the presence of a glutamic acid
residue at position 627, since the PB2 subunits from both
the VN1203 and the WSN strain harbour a lysine at
position 627 (K
627). This suggests that additional determi-
nants within PB2 contribute to virus host-range and
replication efficiency as well (Gabriel et al., 2005; Naffakh
et al., 2000; Shinya et al., 2004).
We also generated complexes in which we substituted the
PB2 subunit in the WSN 3P complex with an avian
(H3N2) PB2 counterpart. Functional analysis of these
complexes revealed that, like the H5N1 PB2 subunit, the
avian PB2 subunit also conferred improved thermotoler-
ance on the WSN 3P complex. Associated host-factors
could possibly contribute to the functional properties of
the purified 3P complex, although future experiments will
be needed to address this question.
Our analyses also showed that the E
627 residue in the avian
PB2 was not required for the enhanced functional activity
of the chimeric W/W/N. The E627K mutation in the avian
PB2 led to only a slight increase in thermotolerance.
Studies that have described the role of PB2 amino acid
residue 627 as a determinant of cold sensitivity of avian
influenza viruses were performed using transcription–
replication experiments (Labadie et al., 2007; Massin
et al., 2001) or by studying the replication of infectious,
recombinant viruses (Hatta et al., 2007; Salomon et al.,
2006). These assays effectively examine both RNA tran-
scription and genome replication, since a defect in either
process would lead to a reduction in measured overall
replication. In contrast, our experiments examined only
viral transcription. Since viral transcription and replication
occur via distinct mechanisms, our findings suggest that
PB2 residues other than amino acid 627 may regulate
temperature sensitivity of viral transcription – and that
mutations at these residues may contribute to virus-host
Fig. 6. An avian PB2 subunit confers enhanced thermostability on
the WSN 3P complex. Equivalent amounts of polymerase complex
(as determined by polymerase activity at 30 6C) were pre-
incubated at 30 6C in the absence of vRNA for different time
periods. The complexes were then tested in an ApG-primed
transcription assay (30 6C, 1 h). (a) A representative autoradio-
gram and (b) quantitative data from replicate experiments are
shown. The data were normalized to the amount of fully extended
product where no pre-incubation was performed (as quantified by
Phosphorimager analysis). Mean transcriptional activities from at
least four independent assays are shown. Bars, SEM. A nonlinear
curve for a single-phase exponential decay was fitted to the data
using GraphPad Prism. The r
2 value (goodness of fit) for the W/W/
W curve was 0.81, and the half-life of the W/W/W complex was
estimated at 7.3 min (with 95% confidence intervals ranging from
5.3 to 11.8 min). The half-life of the W/W/N complex could not be
determined, as it exceeded the 2 h of our analysis. (c) The purified
WSN 3P complex was pre-incubated at the indicated tempera-
tures in the presence (left panel) or absence of both 59- and 39-
vRNA (right panel). The proteins were pulled-down with NiNTA
Magnetic Agarose Beads and detected by immunoblotting with
antibodies directed against PA (anti-His), PB1 and PB2.
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replication, through effects on RNA transcription (Chen
et al., 2006; Finkelstein et al., 2007). Further studies to
address this hypothesis are ongoing.
At the mechanistic level, our results show that the
thermotolerance-enhancing activity of the avian PB2 can
be attributed to an increase in functional stability of the
polymerase complex. Brownlee & Sharps (2002) have
speculated that, in the absence of the vRNA promoter, the
WSN polymerase complex is open and labile to heat
inactivation. We showed that the half-life of the WSN
complex in the absence of vRNA was roughly 10 min at
30 uC, whereas the functional half-life of the W/W/N
complex exceeded 2 h. The short functional half-life of the
WSN complex was not due to disintegration or disassem-
bly of the tripartite polymerase protein complex, since the
complex remained intact for at least 1 h.
Our findings support the earlier hypothesis (Brownlee &
Sharps, 2002) that avian IAV RNA polymerases may have
increased heat stability, due to the need of avian viruses to
replicate at elevated temperatures present in birds.
Brownlee also hypothesized that highly pathogenic human
influenza viruses may possess polymerases with increased
thermostability, relative to less pathogenic strains. Our
results provide support for both of these predictions, and
suggest the need to examine the thermostability of RNA
polymerases from additional viruses.
In conclusion, the results reported in this paper define a
new and previously unappreciated role for the influenza
PB2 protein in determining the thermostability of the virus
RNA polymerase. Future studies will determine the specific
amino acid residues that contribute to this property, and
will assess whether increased thermostability is associated
with greater pathogenicity and/or host adaptation by
emerging influenza viruses.
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